The White House's booster push was reportedly prompted in part by supply fears


The White House push for a September COVID-19 booster shot rollout was at least in part motivated by supply concerns, Politico reports.
Top advisers reportedly encouraged Biden to announce the booster plan in case the U.S. ran "short of doses needed to offer the shots to its entire population if vaccines' protection decreased suddenly," Politico writes, according to the account of two senior officials. The administration wanted to ensure there were enough doses for the 40 percent still in need of their first shot, as well as those who would eventually need some reinforcement.
The deliberations "underscore the extent to which top Biden administration officials were guided by concerns about future American vaccine supply, not just international data on vaccine performance, in developing their vision of a sweeping booster rollout," Politico writes. "No one wants to be the person responsible for not having the doses when we need them," said one individual.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The concern, however, is that by stockpiling even more doses for domestic use, the U.S. will encourage other wealthy countries to follow suit, "tightening an already strained international manufacturing system," and perhaps impacting U.S. donations to low-income countries, Politico writes. Some officials and experts have argued the focus should instead be on ramping up global vaccination rates to prevent the emergence of new variants.
Said Celine Gounder, an infectious disease specialist: "You basically would have high income and some low-and middle-income countries that would be getting third doses, and then you would have lower-income countries with nothing."
On Friday, a Food and Drug Administration advisory panel voted against recommending the use booster shots of the Pfizer-BioNTech vaccine for people 16 and older, instead endorsing a narrower plan to administer extra doses to those 65 and older and those deemed high-risk. Read more at Politico.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Trump uses tariffs to upend Brazil's domestic politics
IN THE SPOTLIGHT By slapping a 50% tariff on Brazil for its criminal investigation into Bolsonaro, the Trump administration is brazenly putting its fingers on the scales of a key foreign election
-
3 questions to ask when deciding whether to repair or replace your broken appliance
the explainer There may be merit to fixing what you already have, but sometimes buying new is even more cost-effective
-
'Trump's authoritarian manipulation of language'
Instant Opinion Vienna has become a 'convenient target for populists' | Opinion, comment and editorials of the day
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'